Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Frontiers in Pharmacology|July 9, 2019
Immunomodulatory Therapeutic Strategies in StrokeKyle Malone, Sylvie Amu, Anne C Moore, et al.Immunology and Cell Biology|July 20, 2018
The immune system and stroke: from current targets to future therapyKyle Malone, Sylvie Amu, Anne C Moore, et al.European Journal of Immunology|June 27, 2023
The impact of fingolimod on Treg function in brain ischaemiaKyle Malone, Jennifer A Shearer, Christian Waeber, et al.Data in Brief|June 7, 2021
Histological, behavioural and flow cytometric datasets relating to acute ischaemic stroke in young, aged and ApoE-/- mice in the presence and absence of immunomodulation with fingolimodAndrea C Diaz Diaz, Kyle Malone, Jennifer A Shearer, et al.Journal of Neuroinflammation|January 31, 2021
The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemiaKyle Malone, Andrea C Diaz Diaz, Jennifer A Shearer, et al.Frontiers in Pharmacology|August 1, 2022
Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as ComorbiditiesAndrea C Diaz Diaz, Kyle Malone, Jennifer A Shearer, et al.Brain, Behavior, & Immunity - Health|September 19, 2022
Recombinant pregnancy-specific glycoprotein-1-Fc reduces functional deficit in a mouse model of permanent brain ischaemiaKyle Malone, Jennifer A Shearer, John M Williams, et al.Frontiers in Pharmacology|January 25, 2021
Acute Treatment With Fingolimod Does Not Confer Long-Term Benefit in a Mouse Model of Intracerebral HaemorrhageAndrea C Diaz Diaz, Jennifer A Shearer, Kyle Malone, et al.Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-DionesRyan D Kruschel, Kyle Malone, Alison N Walsh, et al.Clinical & Developmental Immunology|September 24, 2011
Phenotype and function of CD25-expressing B lymphocytes isolated from human umbilical cord bloodSylvie Amu, Mikael BrisslertPageof 16